EVP, CHIEF FINANCIAL OFFICERCIK 0001899977
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER |  ACADACADIA PHARMACEUTICALS INCOpen-market sale | SELL | $69K 3,321 sh | Oct 30, 2026 traded Oct 30, 2026 | |
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER |
| ACADACADIA PHARMACEUTICALS INC Grant or award |
| A |
| — 6,815 sh |
| Oct 30, 2026 traded Oct 15, 2026 |
| 0 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | — 14.3K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 2 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | $104K 5,849 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 8 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $170K 5,849 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 8 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $273K 9,292 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 0 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | — 5,849 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 6 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | $255K 14.3K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 5 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $145K 5,000 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 35 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale | SELL | $60K 2,709 sh | Apr 7, 2026 traded Apr 7, 2026 |
| 5 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Option exercise | M | — 5,276 sh | Apr 7, 2026 traded Apr 5, 2026 |
| 9 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Option exercise | M | — 5,276 sh | Apr 7, 2026 traded Apr 5, 2026 |
| 17 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Option exercise | M | — 8,138 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 9 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Option exercise | M | — 8,138 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 39 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale | SELL | $90K 4,177 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 9 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Option exercise | M | — 6,178 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 35 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale | SELL | $69K 3,171 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 32 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale | SELL | $804 37 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 17 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Option exercise | M | — 6,178 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 33 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale | SELL | $243K 10.3K sh | Nov 19, 2025 traded Nov 18, 2025 |
| 17 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Option exercise | M | — 9,913 sh | Nov 19, 2025 traded Nov 17, 2025 |
| 13 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Option exercise | M | — 9,913 sh | Nov 19, 2025 traded Nov 17, 2025 |
| 9 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Option exercise | M | — 9,913 sh | Nov 19, 2025 traded Nov 17, 2025 |
| 9 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Option exercise | M | — 9,913 sh | Nov 19, 2025 traded Nov 17, 2025 |